Dick de Zeeuw discusses a trial looking at the effect of statins on renal function.

Lawrence Phillips talks about a study looking at the effects of a lifestyle programme on diabetes incidence and weight loss in a real-world population in the USA.

Edward Gregg from the US Centers for Disease Control discusses the rise in US diabetes incidence, and a concurrent fall in mortality from diabetes.

John Deanfield discusses lifetime changes in BMI and cardiovascular risk.

John Wentworth and Paul O'Brien discuss a randomized trial of bariatric surgery for overweight, non-obese people with type 2 diabetes.

Dr Rowan Gillies joins Natalie Harrison to discuss surgery for people with diabetes in low-income and middle-income countries.

Norbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.

Mark Bolland discusses the results of a sequential trial meta-analysis of the effects of vitamin D supplementation on skeletal, vascular, and cancer outcomes.

Michael Nauck discusses incretin-based drugs and pancreatitis risk.

Ambady Ramachandran discusses using text messaging to prevent diabetes in men at high risk of developing the disease.